| ID: 132089012 | Neanderthal introgressed variant-containing enhancer experimental_72694 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121761009..121761178) | | |
| ID: 129993036 | ATAC-STARR-seq lymphoblastoid active region 21872 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121870175..121870404) | | |
| ID: 129993035 | ATAC-STARR-seq lymphoblastoid active region 21871 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121823662..121823731) | | |
| ID: 129993034 | ATAC-STARR-seq lymphoblastoid active region 21870 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121823422..121823471) | | |
| ID: 129993033 | ATAC-STARR-seq lymphoblastoid active region 21868 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121788913..121788962) | | |
| ID: 129993032 | ATAC-STARR-seq lymphoblastoid silent region 15660 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121726886..121727065) | | |
| ID: 129993031 | ATAC-STARR-seq lymphoblastoid silent region 15659 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121696929..121697348) | | |
| ID: 127401450 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr4:122721667-122722470 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121800512..121801393) | | |
| ID: 127401449 | OCT4-NANOG hESC enhancer GRCh37_chr4:122670301-122670904 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121749146..121749749) | | |
| ID: 127401448 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr4:122669697-122670300 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121748542..121749145) | | |
| ID: 126807145 | MED14-independent group 3 enhancer GRCh37_chr4:122633152-122634351 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121711550..121713196) | | |
| ID: 126807144 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr4:122611545-122612744 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121690390..121691589) | | |
| ID: 121056742 | Sharpr-MPRA regulatory region 4891 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121794494..121794788) | | |
| ID: 105377402 | uncharacterized LOC105377402 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121643195..121650651, complement) | | |
| ID: 100192379 | uncharacterized LOC100192379 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121764585..121766808) | | |
| ID: 132332 | small integral membrane protein 43 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121758930..121765433, complement) | NEMEP, TMEM155 | |
| ID: 55212 | Bardet-Biedl syndrome 7 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121824329..121870474, complement) | BBS2L1 | 607590 |
| ID: 5393 | exosome component 9 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121801323..121817021) | PCH1D, PM/Scl-75, PMSCL1, RRP45, Rrp45p, p5, p6 | 606180 |
| ID: 890 | cyclin A2 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121816444..121823883, complement) | CCN1, CCNA | 123835 |
| ID: 308 | annexin A5 [Homo sapiens (human)] | Chromosome 4, NC_000004.12 (121667946..121696980, complement) | ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3, VAC-alph | 131230 |